Our Scientific Advisers
Adam Rosenthal, MB, BS, BSc (hons), PhD., FRCOG
Adam Rosenthal is one of the UK’s most experienced ovarian screening clinicians, working as a Consultant Gynecologist at Princess Grace Hospital and University College Hospital (UCH). He has been involved in ovarian cancer screening research and looking after women at increased risk of the disease since 1997 and has been Clinical Lead on the UK Familial Ovarian Cancer Screening Study since 2004. He has sat on the UK Cancer Genetics Group Steering Committee and is a Medical Advisor to the charities The Eva Appeal, Ovacome and Ovarian Cancer Action.
Barry M. Berger, MD, FCAP
Barry M. Berger MD FCAP is the Chief Medical Officer for Exact Sciences Corporation (EXAS, Madison, WI USA), a developer of advanced DNA based tests for colorectal cancer screening. Dr. Berger currently serves on the Executive Committee of the Massachusetts Society of Pathologist and the Policy Committee of the National Colorectal Cancer Roundtable. He is a founding partner and current BOD member of HealthMetrics Partners, a member of the scientific advisory boards of SynapDx, Corp., Abcodia, and a mentor/catalyst in Massachusetts Institute of Technology Deshpande Center for Technological Innovation and faculty of the Harvard Catalyst program.